GRP
DYN icon

Global Retirement Partners’s Dyne Therapeutics DYN Stock Holding History

Global Retirement Partners’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.87K Buy
+84
New +$1.56K ﹤0.01% 4050
2024
Q4 		$71 Buy
+3
New +$89 ﹤0.01% 3563

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Global Retirement Partners's DYN Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Dyne Therapeutics (DYN) in Q2 2026: 84 shares worth $1.87K. The stake represents ﹤0.01% of the portfolio and ranks #4050 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in DYN as recently as Q4 2024.

Global Retirement Partners first reported a position in DYN in Q4 2024 and has held it in 2 quarters since. 245 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Global Retirement Partners held 84 shares of Dyne Therapeutics worth $1.87K as of Q2 2026.
  • Dyne Therapeutics was a new Global Retirement Partners position in Q2 2026.
  • Dyne Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #4050 holding.
  • Global Retirement Partners first reported a position in Dyne Therapeutics in Q4 2024 and has held it in 2 quarters since.
  • 245 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.